Cargando…
Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme
Background: It is known that adverse reactions following SARS-CoV-2 vaccinations show a positive correlation with the subsequent antibody titer. However, it is not clear how the adverse reactions following the booster vaccination are related to the antibody levels that can be measured after a 3rd do...
Autores principales: | Kanizsai, Andrea, Zavori, Laszlo, Molnar, Tihamer, Tőkés-Füzesi, Margit, Szalai, Zoltan, Berecz, Janos, Varnai, Reka, Peterfi, Zoltan, Schwarcz, Attila, Csecsei, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864400/ https://www.ncbi.nlm.nih.gov/pubmed/36680026 http://dx.doi.org/10.3390/vaccines11010182 |
Ejemplares similares
-
Fever after Vaccination against SARS-CoV-2 with mRNA-Based Vaccine Associated with Higher Antibody Levels during 6 Months Follow-Up
por: Kanizsai, Andrea, et al.
Publicado: (2022) -
Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022) -
Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms
por: Molnar, Tihamer, et al.
Publicado: (2021) -
Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome
por: Zavori, Laszlo, et al.
Publicado: (2023) -
Acute Phase Protein Orosomucoid (Alpha-1-Acid Glycoprotein) Predicts Delayed Cerebral Ischemia and 3-Month Unfavorable Outcome after Aneurysmal Subarachnoid Hemorrhage
por: Zavori, Laszlo, et al.
Publicado: (2023)